Detalhe da pesquisa
1.
American College of Rheumatology/EULAR remission criteria for rheumatoid arthritis: 2022 revision.
Ann Rheum Dis
; 82(1): 74-80, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36280238
2.
Efficacy of synthetic and biological DMARDs: a systematic literature review informing the 2022 update of the EULAR recommendations for the management of rheumatoid arthritis.
Ann Rheum Dis
; 82(1): 95-106, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36368906
3.
Efficacy, duration of use and safety of glucocorticoids: a systematic literature review informing the 2022 update of the EULAR recommendations for the management of rheumatoid arthritis.
Ann Rheum Dis
; 82(1): 81-94, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36410794
4.
EULAR recommendations for the non-pharmacological management of systemic lupus erythematosus and systemic sclerosis.
Ann Rheum Dis
; 2023 Aug 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-37433575
5.
2021 EULAR points to consider to support people with rheumatic and musculoskeletal diseases to participate in healthy and sustainable paid work.
Ann Rheum Dis
; 82(1): 57-64, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36109139
6.
EULAR points to consider for the definition of clinical and imaging features suspicious for progression from psoriasis to psoriatic arthritis.
Ann Rheum Dis
; 82(9): 1162-1170, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37295926
7.
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update.
Ann Rheum Dis
; 82(1): 3-18, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36357155
8.
Consensus statement on blocking interleukin-6 receptor and interleukin-6 in inflammatory conditions: an update.
Ann Rheum Dis
; 82(6): 773-787, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35953263
9.
EULAR points to consider when analysing and reporting comparative effectiveness research using observational data in rheumatology.
Ann Rheum Dis
; 81(6): 780-785, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35058229
10.
2021 update of the EULAR points to consider on the use of immunomodulatory therapies in COVID-19.
Ann Rheum Dis
; 81(1): 34-40, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34620584
11.
2022 EULAR points to consider for remote care in rheumatic and musculoskeletal diseases.
Ann Rheum Dis
; 81(8): 1065-1071, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35470160
12.
Influence of COVID-19 pandemic on decisions for the management of people with inflammatory rheumatic and musculoskeletal diseases: a survey among EULAR countries.
Ann Rheum Dis
; 80(4): 518-526, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33158877
13.
2021 EULAR recommendations for the implementation of self-management strategies in patients with inflammatory arthritis.
Ann Rheum Dis
; 80(10): 1278-1285, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33962964
14.
2019 EULAR points to consider for non-physician health professionals to prevent and manage fragility fractures in adults 50 years or older.
Ann Rheum Dis
; 80(1): 57-64, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32332077
15.
2020 EULAR points to consider for the prevention, screening, assessment and management of non-adherence to treatment in people with rheumatic and musculoskeletal diseases for use in clinical practice.
Ann Rheum Dis
; 80(6): 707-713, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33355152
16.
EULAR points to consider on pathophysiology and use of immunomodulatory therapies in COVID-19.
Ann Rheum Dis
; 80(6): 698-706, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33547062
17.
Testing different thresholds for patient global assessment in defining remission for rheumatoid arthritis: are the current ACR/EULAR Boolean criteria optimal?
Ann Rheum Dis
; 79(4): 445-452, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32024651
18.
EULAR provisional recommendations for the management of rheumatic and musculoskeletal diseases in the context of SARS-CoV-2.
Ann Rheum Dis
; 79(7): 851-858, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32503854
19.
EULAR points to consider for the use of big data in rheumatic and musculoskeletal diseases.
Ann Rheum Dis
; 79(1): 69-76, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31229952
20.
EULAR/eumusc.net standards of care for rheumatoid arthritis: cross-sectional analyses of importance, level of implementation and care gaps experienced by patients and rheumatologists across 35 European countries.
Ann Rheum Dis
; 79(11): 1423-1431, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32873554